Efficacy of single-dose HPV vaccination among young African women

BACKGROUND: Single-dose HPV vaccination, if efficacious, would be tremendously advantageous; simplifying implementation and decreasing costs. METHODS: We performed a randomized, multi-center, double-blind, controlled trial of single-dose nonavalent (HPV 16/18/31/33/45/52/58/6/11) or bivalent (HPV 16...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnabas, Ruanne V., Brown, Elizabeth R., Onono, Maricianah A., Bukusi, Elizabeth A., Njoroge, Betty, Winer, Rachel L., Galloway, Denise A., Pinder, Leeya F., Donnell, Deborah, Wakhungu, Imelda, Congo, Ouma, Biwott, Charlene, Kimanthi, Syovata, Oluoch, Linda, Heller, Kate B., Leingang, Hannah, Morrison, Susan, Rechkina, Elena, Cherne, Stephen, Schaafsma, Torin T., McClelland, R. Scott, Celum, Connie, Baeten, Jared M., Mugo, Nelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NEJM Group, a division of the Massachusetts Medical Society 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172784/
https://www.ncbi.nlm.nih.gov/pubmed/35693874
http://dx.doi.org/10.1056/EVIDoa2100056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172784/
https://www.ncbi.nlm.nih.gov/pubmed/35693874
http://dx.doi.org/10.1056/EVIDoa2100056

Ejemplares similares